longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

R&G Pharma: Net profit of 61.1161 million yuan in the first half of 2025, a year-on-year increase of 4.45%

Zhitong
Aug 27, 2025 at 11:13 AM

R&G Pharma announced that its operating revenue in the first half of 2025 was 380 million yuan, a year-on-year increase of 0.18%. The net profit was 61.1161 million yuan, a year-on-year increase of 4.45%

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 10, 2026 at 05:40 AMWorld’s largest contract chipmaker TSMC sees August revenue surge over 53% to record high
R&G Pharma

R&G Pharma

301333.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI